Standardized Measure of Premenstrual Symptoms Among Transgender Men and Gender-Diverse Adults

Overview

About this study

The purpose of this study is to obtain preliminary quantitative and qualitative data on the validity of the Premenstrual Symptoms Screening Tool (PSST) in TGD adults. Also, to obtain preliminary quantitative data to assess potential differential effects of gender identity, gender dysphoria, somatic symptom burden, adverse childhood events, anxiety, and depression on responses to the PSST.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Individuals aged 18 years of age, or older, with lived experience of menstruation.

Exclusion Criteria:

  • Lack of lived experience of menstruation or inability or unwillingness to complete the survey for any reason; Do not self-identify as one of the three groups under study (i.e., binary transgender men, non-binary adults, cisgender women).

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 11/15/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Fiona Fonseca, M.B., B.Ch., B.A.O., M.S.

Open for enrollment

Contact information:

Fiona Fonseca M.B., B.Ch., B.A.O., M.S.

(507) 284-2933

RainbowResearch@mayo.edu

More information

Publications

Publications are currently not available